Physician profile
Jack Pinney
NPI 1982617247
$67,031.50
in general payments reported to CMS, 2019-2025
9 companies · $19.99 in 2025
The $19.99 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,512 · 2021: $27K · 2022: $26K · 2023: $1,428 · 2024: $62.26 · 2025: $19.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,375 · Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,375.00 |
| Food and Beverage | $135.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $47,669.34 | 2021-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $19,128.94 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $53.06 | 2023-2024 | Euflexxa |
| Pacira Therapeutics, INC. | $45.92 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $45.31 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $32.33 | 2022 | |
| Bioventus LLC | $19.99 | 2025 | Gelsyn-3 |
| Djo, LLC | $19.18 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Pinney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.